Relevant bibliographies by topics / Insulin-like growth factor

Academic literature on the topic 'Insulin-like growth factor'

Author: Grafiati
Published: 4 June 2021
Last updated: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Insulin-like growth factor.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Insulin-like growth factor"

1

Purwana, Arie, Budiono Budiono, Jose RL Batubara, and Muhammad Faizi. "Association of Growth Velocity with Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Levels in Children with a Vegan Diet." Journal of Biomedicine and Translational Research 6, no. 1 (February 6, 2020): 6–10. http://dx.doi.org/10.14710/jbtr.v6i1.5474.

Full text
Abstract:
Background: The vegan diet in children provides the benefit of reducing the risk of being overweight and improving the fat profile. The risk that can occur in the provision of a vegan diet in children is anthropometric size below reference and low caloric intake. Growth hormone (GH) and Insulin like Growth Factors (IGFs) are powerful stimulators for longitudinal growth of bone and require insulin-like growth factor binding protein (IGFBPs) which acts as a transport protein for IGF-1. A vegan diet with lower calorie intake in children has lower IGF-I levels than children with an omnivorous diet.Objective: Examining the effect of vegan diets on IGF-1 levels, IGFBP-3 levels, and growth velocity.Methods: This study was done with a prospective cohort design. The study subjects were divided into two groups, namely the vegan group and the omnivorous group, then matched based on age and sex. During the study, anthropometric data collection, IGF-1 and IGFBP-3 levels measurements were done in both vegan children and omnivorous children.Results: During 6 months of observation, 22 subjects were divided into two groups, namely children with a vegan diet and children with an omnivorous diet. IGF-1 (ng / mL) in vegan children was 105.5 ± 47.3 compared to 102.7 ± 42.3 in omnivorous children with a value of p = 0.89. IGFBP-3 (ng / mL) in vegan children was 2146.4 ± 595.1 compared to 2142 ± 609.1 in omnivorous children with value of p = 0.99 and Growth Velocity (cm / 6 months) was 3.0 in vegan children (1.0-5.30), and 3.2 (2.6-6.5) in omnivorous children with value of p = 0.41.Conclusion:Children with vegan diet had IGF-1 level, IGFBP-3 level, and growth velocity that were the same as children with an omnivorous diet.
APA, Harvard, Vancouver, ISO, and other styles
2

Le Roith, Derek. "Insulin-Like Growth Factor." Hormone and Metabolic Research 31, no. 02/03 (January 1999): 41–42. http://dx.doi.org/10.1055/s-2007-978696.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gu, Lijuan, Eun-Kyoung Mo, ZheMing Fang, BaiShen Sun, XueMei Zhu, and Chang-Keun Sung. "Partial Purification and Quantification of Insulin-like Growth Factor-I from Red Deer Antler." Journal of Life Science 17, no. 10 (October 30, 2007): 1321–29. http://dx.doi.org/10.5352/jls.2007.17.10.1321.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kostecká, Z., and J. Blahovec. "Animal insulin-like growth factor binding proteins and their biological functions." Veterinární Medicína 47, No. 2 - 3 (March 30, 2012): 75–84. http://dx.doi.org/10.17221/5807-vetmed.

Full text
Abstract:
Insulin-like growth factor (IGF-I, IGF-II) action is influenced by until today known eight forms of insulin-like growth factor binding proteins (IGFBPs). They have been obtained not only from some human and animal tissues and body fluids but also from conditioned medium of cell cultures. An important biological property of the IGFBPs is their ability to increase the circulating half-life of the IGFs. They are able to act as potentiators of cell proliferation. As IGFBPs bind to cell surfaces, they may act either to deliver the IGFs to those surfaces for activation of specific receptors or to activate cell responses independently of receptor activation. Phosphorylation, glycosylation and proteolysis of IGFBPs influence their affinity to IGFs. The IGFBPs in the role of inhibitors may block the activity of the IGFs and be used for antimitogenic therapy. In the last time measuring of IGFBPs levels can be used for diagnosis determination of some endocrine diseases or in differential diagnostics.
APA, Harvard, Vancouver, ISO, and other styles
5

Donath, Marc Y., and J??rgen Zapf. "Insulin-Like Growth Factor I." Drugs & Aging 15, no. 4 (1999): 251–54. http://dx.doi.org/10.2165/00002512-199915040-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Arvat, Emanuela, Fabio Broglio, and Ezio Ghigo. "Insulin-Like Growth Factor I." Drugs & Aging 16, no. 1 (January 2000): 29–40. http://dx.doi.org/10.2165/00002512-200016010-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bortvedt, Sarah F., and P. Kay Lund. "Insulin-like growth factor 1." Current Opinion in Gastroenterology 28, no. 2 (March 2012): 89–98. http://dx.doi.org/10.1097/mog.0b013e32835004c6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nissley, Peter, and Wlodzimierz Lopaczynski. "Insulin-Like Growth Factor Receptors." Growth Factors 5, no. 1 (January 1991): 29–43. http://dx.doi.org/10.3109/08977199109000269.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Colbert, Lisa H., Clifford J. Rosen, Bret H. Goodpaster, Anne B. Newman, Stephen B. Kritchevsky, Suzanne Satterfield, Alka M. Kanaya, Dennis R. Taaffe, and Tamara B. Harris. "Insulin-Like Growth Factor-1." Journal of the American Geriatrics Society 52, no. 11 (November 2004): 1962–63. http://dx.doi.org/10.1111/j.1532-5415.2004.52529_1.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Verhage, A. R., and E. F. H. van Bommel. "Insulin-like growth factor-l." European Journal of Gastroenterology & Hepatology 10, no. 12 (December 1998): A68. http://dx.doi.org/10.1097/00042737-199812000-00220.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Insulin-like growth factor"

1

Robertson, James Gray. "Insulin-like growth factors and insulin-like growth factor binding proteins in wounds /." Title page, contents and abstract only, 1999. http://web4.library.adelaide.edu.au/theses/09PH/09phr6509.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Clark, Sarah Jane. "The growth hormone, insulin-like growth factor, insulin-like growth factor binding proteins and insulin axis in acute liver failure." Thesis, King's College London (University of London), 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.397943.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Watanabe, Shin. "Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin." Kyoto University, 2011. http://hdl.handle.net/2433/142074.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mörth, Corinna. "Consequences of postnatal insulin-like growth factor II overexpression in insulin-like growth factor I deficient mice." Diss., lmu, 2005. http://nbn-resolving.de/urn:nbn:de:bvb:19-46307.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Burns, Jason Lee. "Growth control by insulin-like growth factor II." Thesis, University of Oxford, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.270285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Alsabban, Abdulrahman Essam. "Establishing methods to screen novel small molecules targeting insulin-like growth factor/insulin-like growth factor binding protein interaction." Thesis, University of British Columbia, 2013. http://hdl.handle.net/2429/45046.

Full text
Abstract:
Insulin-like growth factors (IGFs) are important systemic mediators of growth and survival that suppress apoptosis and promote cell cycle progression, angiogenesis and metastatic activities in various cancers by activating IGF-IR tyrosine kinase-mediated signaling. These effects depend on the bioavailability of IGFs, which is regulated by IGF binding proteins (IGFBPs). Increased IGFBP-2 and IGFBP-5 expression observed in castration-resistant prostate cancer is thought to promote tumor progression by enhancing IGF-mediated signaling. IGFBPs have cooperative carboxy-terminal and amino-terminal low and a high affinity IGF binding sites. I hypothesize that blocking the high affinity IGF binding site can affect the bioavailability of IGFs to target tissues and thus be used for treatment of various IGF-responsive diseases including prostate cancer. I initially characterized immunologic reagents capable of being used in sandwich ELISA formats to detect IGF-I and IGFBP-5 and attempted several configurations to establish an IGF-I/IGFBP-5 “bridged” sandwich ELISA platform to measure association and dissociation of IGF-I/IGFBP-5 complex formation. The inability of all bridged ELISA formats tested to measure IGF-I/IGFBP-5 binding, lead me to developed a Bio-Layer Interferometry-based assay that measures IGF-I/ IGFBP-5 binding kinetics that will allow for screening of factors that can affect this intermolecular interaction. I demonstrated that biotinylated IGF-I bound to streptavidin-coated biosensors can be used to measure binding of recombinant IGFBP-5 [2.24 nm shift in optical density (Response)]. I also demonstrated that IGF-I could efficiently disrupt this interaction (0.21 nm shift), while the amino-terminal IGF-I mutant, E3R, exhibits an intermediate competitive activity (1.47 nm shift) and insulin exhibits a low competitive activity (1.83 nm shift). In addition, I demonstrated that IGF-I can competitively disrupted this interaction, resulting in a dissociation rate constant (Kdis 1.5-³ 1/s), In contrast, the amino terminal IGF-I mutant, E3R binds with an intermediate affinity (Kdis 5.6-⁴ 1/s), and buffer free sample results in a (Kdis) of 1.5-⁴ (1/s). These results demonstrate the capacity of this BLI-based assay to differentiate relative competitive activity of compounds that target the high affinity IGF-I binding site of IGFBPs and establish a platform to screen for factors that might be developed as rationale therapeutics to disrupt sequestration of IGF-I by IGFBPs.
APA, Harvard, Vancouver, ISO, and other styles
7

Schaffer, Andrea. "Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and the risk of cervical squamous intraepithelial lesions." Thesis, McGill University, 2004. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=81435.

Full text
Abstract:
Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) have been associated with an increased risk of several cancers. This case-control study investigated the relationship between IGF-I and IGFBP-3 plasma levels and the risk of squamous intraepithelial lesions (SILs) of the cervix, as well as the risk of HPV infection in women. 366 cases and 366 controls were recruited from five Montreal area hospitals. There was a significantly decreased risk of LSIL for the highest quartile of IGFBP-3 relative to the lowest quartile (Odds Ratio (OR)=0.25, 95% confidence interval (CI) 0.08-0.77), adjusted for age, HPV status and IGF-I. Also, there was a significantly increased risk of being positive for HPV, specifically high-risk types, for the highest quartiles of IGFBP-3 relative to the lowest quartile in controls (OR=4.53, 95% CI 1.33-15.40), adjusted for age and IGF-I. IGF-I was not significantly associated with SILs or HPV infection.
APA, Harvard, Vancouver, ISO, and other styles
8

Glassford, Janet. "Regulation of insulin-like growth factor-I bioactivity." Thesis, University of Cambridge, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.624728.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Holmes, Robert. "The maternal insulin-like growth factor system and fetal growth." Thesis, University of Bristol, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.265467.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dickey, Lindsey Ann. "Peripheral Hormone Interactions with the Growth Hormone-Insulin-Like Growth Factor (GH-IGF) System in Rainbow Trout." Diss., North Dakota State University, 2019. https://hdl.handle.net/10365/31353.

Full text
Abstract:
The growth of vertebrates is primarily regulated by the growth hormone-insulin-like growth factor (GH-IGF) system, but not in isolation. The central question of this dissertation was how do other hormones peripheral to the GH-IGF system interact with the system, including feedbacks by GH and IGF themselves on various tissues in rainbow trout (Oncorhynchus mykiss)? The representative hormones selected were thyroxine, cortisol, and the sex steroids testosterone and estrogen, along with GH and IGF. These hormones were chosen because they are known to affect overall growth and development during specific life events, but exactly what target genes and what mechanisms are involved are only at the early stages of being delineated in fish. Liver and gill tissues were selected as representative tissues to assess the in vitro effects on growth-related genes of the GH-IGF system. A total of more than thirty experiments were conducted, including time- and concentration-response, inhibitory studies, hormone combination studies, and radio-receptor binding assays. Hormones were applied to whole tissue cultures and real-time quantitative-PCR was used to measure hormonal effects on GHR, IGF, and IGFR1 genes. Microsomal preparations were treated with selected hormones and radio-labeled GH or IGF. A gamma counter was used to measure receptor-ligand activity. GH and IGF were found to possess autocrine and/or paracrine actions in self-regulating target growth genes. Thyroxine had no direct effects on targeted growth genes but may interact with other molecules or hormones to elicit its effects on growth and development. Cortisol directly influenced target growth genes in a tissue-specific and isoform-specific manner. Finally, sex steroids differentially regulated the growth genes: estradiol inhibited growth genes while testosterone directly stimulated growth genes. These findings contribute to understanding how hormones peripheral to the GH-IGF system interact with the growth system.
National Science Foundation grant IOS 0920116 to Dr. Mark Sheridan
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Insulin-like growth factor"

1

1945-, LeRoith Derek, Zumkeller Walter, and Baxter R. C, eds. Insulin-like growth factors. Georgetown, Tex: Landes Bioscience/Eurekah.com, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1945-, LeRoith Derek, Zumkeller Walter, and Baxter R. C, eds. Insulin-like growth factors. Georgetown, Tex: Eurekah.com, Landes Bioscience, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1945-, LeRoith Derek, ed. Insulin-like growth factors: Molecular and cellular aspects. Boca Raton: CRC Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sekyi-Otu, Ato. Insulin-like growth factor responsiveness in sarcomas. Ottawa: National Library of Canada, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Le Roith, Derek, and Mohan K. Raizada, eds. Current Directions in Insulin-Like Growth Factor Research. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2988-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

1945-, LeRoith Derek, Raizada Mohan K, and International Symposium on Insulin, IGFs, and their Receptors (4th : 1993 : Woods Hole, Mass.), eds. Current directions in insulin-like growth factor research. New York: Plenum, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Varela-Nieto, Isabel, and Julie A. Chowen, eds. The Growth Hormone/Insulin-Like Growth Factor Axis During Development. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/b106814.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Colloque médecine et recherche (8th : 2008 Paris, France). IGFs: Local repair and survival factors throughout life span. Heidelberg: Springer, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

S, Drop Stenvert L., and Hintz Raymond L, eds. Insulin-like growth factor binding proteins: Proceedings of a workshop on insulin-like growth factor binding proteins, Vancouver BC, Canada, June 17-19, 1989. Amsterdam: Excerpta Medica, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Huang, Zhi Hong. Growth hormone, insulin-like growth factor-I and the human ovary. Manchester: University of Manchester, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Insulin-like growth factor"

1

Seth, John. "Insulin-Like Growth Factor-I." In The Immunoassay Kit Directory, 197–203. Dordrecht: Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-1414-1_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Seth, John. "Insulin-Like Growth Factor-II." In The Immunoassay Kit Directory, 204–5. Dordrecht: Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-1414-1_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bidlingmaier, M. "Insulin-like growth factor I." In Lexikon der Medizinischen Laboratoriumsdiagnostik, 1–3. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_1584-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bidlingmaier, M. "Insulin-like growth factor I." In Springer Reference Medizin, 1255–57. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_1584.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sciarra, Amedeo. "Insulin-Like Growth Factor (IGF)." In Endocrine Pathology, 436–38. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-62345-6_5143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pfäffle, Roland, Wieland Kiess, and Jürgen Klammt. "Downstream Insulin-Like Growth Factor." In Developmental Biology of GH Secretion, Growth and Treatment, 42–51. Basel: S. KARGER AG, 2012. http://dx.doi.org/10.1159/000341745.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Salajegheh, Ali. "Insulin Like Growth Factor (IGF)." In Angiogenesis in Health, Disease and Malignancy, 159–68. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-28140-7_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Riley, David S. "Insulin-like Growth Factor-1." In Materia Medica of New and Old Homeopathic Medicines, 107–8. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-25292-1_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sciarra, Amedeo. "Insulin-Like Growth Factor (IGF)." In Encyclopedia of Pathology, 1–3. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-319-28845-1_5143-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jacobs, S. "Insulin-like Growth Factor I Receptors." In Insulin, 267–86. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74098-5_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Insulin-like growth factor"

1

Yerushalmi, R., B. Gilks, T. Nielsen, S. Leang, M. Cheang, R. Woods, K. Gelmon, and H. Kennecke. "Insulin like growth factor in breast cancer subtypes." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-3048.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Doyle, Suzanne L., Claire Donohoe, Joanne Lysaght, Fiona Lithander, Graham Pidgeon, and John V. Reynolds. "Abstract 2283: The role of insulin-like growth factor-1 and insulin like growth factor-1 receptor in obesity and oesophageal cancer." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2283.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rice, Megan S., Rulla M. Tamimi, James L. Connolly, Laura C. Collins, Dejun Shen, Michael N. Pollak, Bernard Rosner, Susan E. Hankinson, and Shelley S. Tworoger. "Abstract A68: Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and lobule type in the Nurses' Health Study II." In Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Oct 22-25, 2011; Boston, MA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1940-6207.prev-11-a68.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nedelkov, Dobrin, Eric Niederkofler, David Phillips, Bryan Krastins, Urban Kiernan, Kemmons Tubbs, and Mary Lopez. "Abstract 2508: Mass spectrometric immunoassay for insulin-like growth factor 1." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2508.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Warnken, M., U. Reitzenstein, M. Fuhrmann, P. Mayer, H. Enzmann, and K. Racke. "Characterization of Proliferative Effects of Insulin and Insulin-Like Growth Factor in Human Airway Epithelial Cells." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4982.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Yee, Douglas, Dedra H. Fagan, Xihong Zhang, Annabell S. Oh, Kelly LaPara, Marc Becker, Deepali Sachdev, and Hua Zhang. "Abstract CN07-02: Disrupting insulin‐like growth factor signaling with monoclonal antibodies." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-cn07-02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Fritton, J. Christopher, Yuki Kawashima, Hui Sun, Yingjie Wu, Wilson Mejia, Hayden W. Courtland, Clifford J. Rosen, and Shoshana Yakar. "Bone Marrow Adipogenesis Is Affected by Insulin-Like Growth Factor-1 Complexes." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206158.

Full text
Abstract:
Fat tissue, which is composed of lipid-filled adipocytes that accumulate during aging, displaces mineralized tissue and reduces the mechanical integrity bone. Bone marrow adipocytes provide stroma for maintenance of mesencymal stem cells (MSC) and reside at sites of bone turnover (i.e., endosteal surfaces where osteoblasts form new bone), potentially influencing cell activity via a paracrine route.
APA, Harvard, Vancouver, ISO, and other styles
8

Bruns, Alexander-Francisco, Jessica Smith, Pooja Shah, Nadira Yuldasheva, Mark T. Kearney, and Stephen Wheatcroft. "145 Insulin-like growth factor binding protein 2 (igfbp2) positively regulates angiogenesis." In British Cardiovascular Society Annual Conference ‘High Performing Teams’, 4–6 June 2018, Manchester, UK. BMJ Publishing Group Ltd and British Cardiovascular Society, 2018. http://dx.doi.org/10.1136/heartjnl-2018-bcs.141.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ibrahim, YH, J. Hartel, K. La Parra, and D. Yee. "Insulin-like growth factor binding protein-1 (IGFBP-1) targets both the insulin-like growth factor (IGF) and integrin pathways for the inhibition of breast cancer cell motility." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-402.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ahasic, Amy M., Rihong Zhai, Li Su, Konstantinos Aronis, Christos S. Mantzoros, B. T. Thompson, and David C. Christiani. "IGFBP3 Polymorphism Is Associated With Plasma Insulin-Like Growth Factor (IGF)-1 And Insulin-Like Growth Factor Binding Protein (IGFBP-3) In An Intensive Care Unit (ICU) Cohort." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3545.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Insulin-like growth factor"

1

Gross, Jennifer M. Insulin-Like Growth Factor Binding Protein-1 Interacts with Integrins to Inhibit Insulin-Like Growth Factor-Induced Breast Cancer Growth and Migration. Fort Belvoir, VA: Defense Technical Information Center, July 2003. http://dx.doi.org/10.21236/ada420347.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cleveland, Rebecca J., Marilie D. Gammon, and Ralph S. Baric. Insulin-Like Growth Factor I Polymorphisms in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2002. http://dx.doi.org/10.21236/ada412654.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Morrison, Tiffany. The Regulation of Insulin-like Growth Factor 1 by Growth Hormone via Stat5b. Portland State University Library, January 2012. http://dx.doi.org/10.15760/honors.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Harbeson, Caroline E., and Steven A. Rosenzweig. The Role of Insulin-Like Growth Factor (IGF) in IGF-Mediated Tumorigenesis. Fort Belvoir, VA: Defense Technical Information Center, July 2004. http://dx.doi.org/10.21236/ada432027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jarrard, David F. Relaxation of Insulin-Like Growth Factor II Imprinting in Prostate Cancer Development. Fort Belvoir, VA: Defense Technical Information Center, January 2005. http://dx.doi.org/10.21236/ada433881.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jarrard, David F. Relaxation of Insulin-Like Growth Factor II Imprinting in Prostate Cancer Development. Fort Belvoir, VA: Defense Technical Information Center, January 2003. http://dx.doi.org/10.21236/ada414797.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jarrard, David F. Relaxation of Insulin-Like Growth Factor II Imprinting in Prostate Cancer Development. Fort Belvoir, VA: Defense Technical Information Center, January 2004. http://dx.doi.org/10.21236/ada423078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Doughterty, Michele K. Insulin Like Growth Factor I Receptor Function in Estrogen Receptor Negative Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2001. http://dx.doi.org/10.21236/ada396720.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bartucci, Monica, and Ewa Surmacz. Cell-Cell Adhesion and Insulin-Like Growth Factor I Receptor in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2001. http://dx.doi.org/10.21236/ada398204.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dougherty, Michele K. Insulin Like Growth Factor 1 Receptor Function in Estrogen Receptor Negative Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2002. http://dx.doi.org/10.21236/ada408990.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Insulin-like growth factor' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography